✦ LIBER ✦

Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate

✍ Scribed by Lucian R. Chirieac; Jonathan C. Trent; Dejka M. Steinert; Haesun Choi; Ying Yang; Jiexin Zhang; Shreyaskumar R. Patel; Robert S. Benjamin; A. Kevin Raymond

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 414 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of Bcl-2 in gastrointestinal

Expression of Bcl-2 in gastrointestinal stromal tumors : Correlation with progression-free survival in 81 patients treated with imatinib mesylate

✍ Dejka M. Steinert; Mauricio Oyarzo; Xuemei Wang; Haesun Choi; Peter F. Thall; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND The natural history of gastrointestinal stromal tumor (GIST) has been revolutionized by imatinib mesylate (imatinib) therapy. Before imatinib, Bcl‐2 expression in GIST was associated with a worse prognosis or added no additional prognostic value. To the authors' knowledge

Surgical treatment of patients with init

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

✍ Piotr Rutkowski; Zbigniew Nowecki; Pawel Nyckowski; Wirginiusz Dziewirski; Urszu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

The role of high-dose imatinib in the ma

The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor

✍ Alessandro Gronchi; Jean-Yves Blay; Jonathan C. Trent 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Early effects of imatinib mesylate on th

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

✍ Jonathan C. Trent; Latha Ramdas; Jheri Dupart; Kelly Hunt; Homer Macapinlac; Ell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

High tumor tissue concentration of plasm

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer

✍ Johanna Nordengren; Margareta Fredstorp Lidebring; Pär-Ola Bendahl; Nils Brünner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 1 views

## Abstract Previous studies including various tumor types have shown different associations between tumor tissue levels of plasminogen activator inhibitor 2 (PAI‐2) and patient survival. High tumor tissue concentrations of PAI‐2 have been associated with good prognosis in patients with breast canc